BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bishop JR, Huang RS, Brown JT, Mroz P, Johnson SG, Allen JD, Bielinski SJ, England J, Farley JF, Gregornik D, Giri J, Kroger C, Long SE, Luczak T, McGonagle EJ, Ma S, Matey ET, Mandic PK, Moyer AM, Nicholson WT, Petry N, Pawloski PA, Schlichte A, Schondelmeyer SW, Seifert RD, Speedie MK, Stenehjem D, Straka RJ, Wachtl J, Waring SC, Ness BV, Zierhut HA, Aliferis C, Wolf SM, McCarty CA, Jacobson PA. Pharmacogenomics education, research and clinical implementation in the state of Minnesota. Pharmacogenomics 2021;22:681-91. [PMID: 34137665 DOI: 10.2217/pgs-2021-0058] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Allen JD, Pittenger AL, Bishop JR. A Scoping Review of Attitudes and Experiences with Pharmacogenomic Testing among Patients and the General Public: Implications for Patient Counseling. JPM 2022;12:425. [DOI: 10.3390/jpm12030425] [Reference Citation Analysis]
2 Mhandire DZ, Goey AKL. The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer Patients. Mol Diagn Ther 2022. [PMID: 35113367 DOI: 10.1007/s40291-021-00575-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mroz P, Michel S, Allen JD, Meyer T, McGonagle EJ, Carpentier R, Vecchia A, Schlichte A, Bishop JR, Dunnenberger HM, Yohe S, Thyagarajan B, Jacobson PA, Johnson SG. Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System. Front Genet 2021;12:712602. [PMID: 34745204 DOI: 10.3389/fgene.2021.712602] [Reference Citation Analysis]